287 related articles for article (PubMed ID: 20020841)
1. Poor drug distribution as a possible explanation for the results of the PRECISE trial.
Sampson JH; Archer G; Pedain C; Wembacher-Schröder E; Westphal M; Kunwar S; Vogelbaum MA; Coan A; Herndon JE; Raghavan R; Brady ML; Reardon DA; Friedman AH; Friedman HS; Rodríguez-Ponce MI; Chang SM; Mittermeyer S; Croteau D; Puri RK;
J Neurosurg; 2010 Aug; 113(2):301-9. PubMed ID: 20020841
[TBL] [Abstract][Full Text] [Related]
2. Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning.
Sampson JH; Brady ML; Petry NA; Croteau D; Friedman AH; Friedman HS; Wong T; Bigner DD; Pastan I; Puri RK; Pedain C
Neurosurgery; 2007 Feb; 60(2 Suppl 1):ONS89-98; discussion ONS98-9. PubMed ID: 17297371
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions.
Sampson JH; Raghavan R; Brady ML; Provenzale JM; Herndon JE; Croteau D; Friedman AH; Reardon DA; Coleman RE; Wong T; Bigner DD; Pastan I; Rodríguez-Ponce MI; Tanner P; Puri R; Pedain C
Neuro Oncol; 2007 Jul; 9(3):343-53. PubMed ID: 17435179
[TBL] [Abstract][Full Text] [Related]
4. Future of convection-enhanced delivery in the treatment of brain tumors.
Bidros DS; Liu JK; Vogelbaum MA
Future Oncol; 2010 Jan; 6(1):117-25. PubMed ID: 20021213
[TBL] [Abstract][Full Text] [Related]
5. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.
Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E
J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805
[TBL] [Abstract][Full Text] [Related]
6. Convection-enhanced delivery for the treatment of glioblastoma.
Vogelbaum MA; Aghi MK
Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii3-ii8. PubMed ID: 25746090
[TBL] [Abstract][Full Text] [Related]
7. Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report.
Ivasyk I; Morgenstern PF; Wembacher-Schroeder E; Souweidane MM
J Neurosurg Pediatr; 2017 Sep; 20(3):256-260. PubMed ID: 28686124
[TBL] [Abstract][Full Text] [Related]
8. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.
Kunwar S; Prados MD; Chang SM; Berger MS; Lang FF; Piepmeier JM; Sampson JH; Ram Z; Gutin PH; Gibbons RD; Aldape KD; Croteau DJ; Sherman JW; Puri RK;
J Clin Oncol; 2007 Mar; 25(7):837-44. PubMed ID: 17327604
[TBL] [Abstract][Full Text] [Related]
9. Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.
Kunwar S; Chang SM; Prados MD; Berger MS; Sampson JH; Croteau D; Sherman JW; Grahn AY; Shu VS; Dul JL; Husain SR; Joshi BH; Pedain C; Puri RK
Neurosurg Focus; 2006 Apr; 20(4):E15. PubMed ID: 16709020
[TBL] [Abstract][Full Text] [Related]
10. Magnetic Resonance Imaging-Based Assessment of Gadolinium-Conjugated Diethylenetriamine Penta-Acetic Acid Test-Infusion in Detecting Dysfunction of Convection-Enhanced Delivery Catheters.
van Putten EH; Wembacher-Schröder E; Smits M; Dirven CM
World Neurosurg; 2016 May; 89():272-9. PubMed ID: 26862025
[TBL] [Abstract][Full Text] [Related]
11. Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model.
Kawakami K; Kawakami M; Kioi M; Husain SR; Puri RK
J Neurosurg; 2004 Dec; 101(6):1004-11. PubMed ID: 15597761
[TBL] [Abstract][Full Text] [Related]
12. Convection-enhanced delivery in the treatment of malignant glioma.
Lopez KA; Waziri AE; Canoll PD; Bruce JN
Neurol Res; 2006 Jul; 28(5):542-8. PubMed ID: 16808887
[TBL] [Abstract][Full Text] [Related]
13. Entry points for catheter placement in convection-enhanced delivery--a retrospective anatomic analysis.
Dörner L; Nabavi A; Mehdorn HM
Minim Invasive Neurosurg; 2009 Oct; 52(5-6):229-32. PubMed ID: 20077363
[TBL] [Abstract][Full Text] [Related]
14. Repeat convection-enhanced delivery for diffuse intrinsic pontine glioma.
Bander ED; Ramos AD; Wembacher-Schroeder E; Ivasyk I; Thomson R; Morgenstern PF; Souweidane MM
J Neurosurg Pediatr; 2020 Sep; 26(6):661-666. PubMed ID: 32977309
[TBL] [Abstract][Full Text] [Related]
15. Convection-enhanced delivery in clinical trials.
Hall WA; Rustamzadeh E; Asher AL
Neurosurg Focus; 2003 Feb; 14(2):e2. PubMed ID: 15727423
[TBL] [Abstract][Full Text] [Related]
16. Convection-Enhanced Delivery for Management of Malignant Gliomas.
Prabhu SS
Prog Neurol Surg; 2018; 32():152-158. PubMed ID: 29990981
[TBL] [Abstract][Full Text] [Related]
17. Clinical tolerance of corticospinal tracts in convection-enhanced delivery to the brainstem.
Morgenstern PF; Zhou Z; Wembacher-Schröder E; Cina V; Tsiouris AJ; Souweidane MM
J Neurosurg; 2018 Dec; 131(6):1812-1818. PubMed ID: 30579270
[TBL] [Abstract][Full Text] [Related]
18. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
Saito R; Tominaga T
Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
[TBL] [Abstract][Full Text] [Related]
19. Benchmarking the ERG valve tip and MRI Interventions Smart Flow neurocatheter convection-enhanced delivery system's performance in a gel model of the brain: employing infusion protocols proposed for gene therapy for Parkinson's disease.
Sillay K; Schomberg D; Hinchman A; Kumbier L; Ross C; Kubota K; Brodsky E; Miranpuri G
J Neural Eng; 2012 Apr; 9(2):026009. PubMed ID: 22331865
[TBL] [Abstract][Full Text] [Related]
20. Convection-enhanced delivery to achieve widespread distribution of viral vectors: Predicting clinical implementation.
Debinski W; Tatter SB
Curr Opin Mol Ther; 2010 Dec; 12(6):647-53. PubMed ID: 21154156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
